Treatment of androgen deprivation therapy associated symptoms
AssigneeEli Lilly and Company
InventorsCharles Thomas BENSON, Rachel Nicole Richey, Hannah Yu
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of treating symptoms associated with Androgen Deprivation Therapy comprising administering to a patient in need of such treatment an effective amount of a compound of Formula I: or a pharmaceutically acceptable salt thereof.
Claims5
A pharmaceutical composition comprising a substantially pure form of (S)-(7-cyano-4-pyridin-2-ylmethyl-1,2,3,4-tetrahydro-cyclopenta[b]indol-2-yl)-carbamic acid isopropyl ester or a pharmaceutically acceptable salt thereof.
A technical grade form of (S)-(7-cyano-4-pyridin-2-ylmethyl-1,2,3,4-tetrahydro-cyclopenta[b]indol-2-yl)-carbamic acid isopropyl ester or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.